Skip to main content
OpenTrials
Completed

NCT Number: NCT02516709

Linear Source Registry for Prostate Cancer

Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Chicago Prostate Cancer Center, Chicago, Illinois, United States

Loading trial locations.

About this study

This registry is being conducted to provide long term analysis on the use of the linear Civastring source for prostate cancer. Prospective data collection will record and demonstrate biochemical response rates. Long term side effects and adverse events will be monitored.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years old
  • Plans to remain in care of enrolling physician for 5 years
  • > 5 years life expectancy
  • Signed informed consent
  • Enrolled within 6 weeks of implant or within 365 days of prior implant

Exclusion criteria

  • Not willing or able to comply with protocol visit schedule

Treatment and study plan

Linear LDR Source

Radiation

The Linear LDR source is a permanent interstitial brachytherapy implant containing palladium-103 sources for the treatment of prostate cancer.

Primary outcomes

  1. Biochemical Response Rate (PSA)

    Time frame: Up to 5 years

Secondary outcomes

  1. Side Effects (IPSS, IIEF, RFAS score)

    Time frame: Up to 5 years

  2. Adverse Events

    Time frame: Up to 5 years

Sponsors and collaborators

Lead sponsor

CivaTech Oncology

Industry

Registry information

Official study title

CivaString Registry for Prostate Cancer

Acronym: CaRePC

Important dates

Study start
2015
Primary completion
2023
Study completion
2023
First posted
Aug 6, 2015
Registry last updated
Sep 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.